# Halma completes sale of NovaBone for $60m

- Link: https://www.directorstalkinterviews.com/halma-completes-sale-of-novabone-for-60m/4121259166
- Published: 2026-08-04T07:21:06+01:00
- Author: Amilia Stone

**[Halma Plc](https://www.directorstalkinterviews.com/ftse-company/halma-plc/hlma.l)**(
LON:HLMA) has completed the sale of NovaBone Products LLC and its subsidiaries to
Isto Biologics for total consideration of $60m (£45m) on a cash and debt free basis.

NovaBone designs and manufactures differentiated orthobiologic products, and is 
headquartered in Florida, US^(1). While NovaBone has developed well under Halma’s
ownership, strengthening its product offering and capabilities, a recent strategic
review concluded that NovaBone is best placed to grow under ownership more closely
aligned to its market and investment needs. Isto Biologics is an established orthobiologics
business with a complementary portfolio and capabilities to support NovaBone’s future
growth.

The divestment reflects Halma’s disciplined approach to capital allocation and enables
continued focus on areas where it sees the strongest opportunities for long-term
growth and returns.

> **Marc Ronchetti, Group Chief Executive,** **commented**:
> “We are pleased to have found a new home for NovaBone. Isto Biologics’ deep industry
> expertise and complementary portfolio make it a clear strategic fit for NovaBone,
> while enabling Halma to continue focusing investment in areas where we see the
> best opportunities for long-term growth and returns. I would like to thank the
> NovaBone leadership team and all its employees for their contribution to the Group.
> We wish them every success for the future.”

Share on: